Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: J Affect Disord. 2020 Jul 15;276:453–460. doi: 10.1016/j.jad.2020.07.025

Table 2.

Individual study requirements for participant inclusion and treatment continuation

Author Required Failure or Intolerance of Previous Pharmacologic Treatment Number of Courses/Medications Concomitant Medication or Therapy Occurred
Carpenter Yes 1+ Stable, ongoing psychotherapy permitted
Clarke Yes 2+ (44.4% previously treated with ECT) Treating psychiatrists requested not to make changes to patients’ medication immediately before or during rTMS treatment
Gwynette Yes 2+ Yes, medication regimes stable for 1+ months allowed
Kumar Yes 2+ -
Mantovani Yes, included if symptomatic despite treatment with an adequate medication trial 1+ Yes, stable medication regimes (1+ months) and therapy regimes (3+) months allowed
Philip (2016) Yes; were in treatment at VA PTSD clinic “inclusive of medication and psychotherapy”
Philip (2019) Yes, included “if applicable” if symptomatic despite stable treatment for at least 6 weeks Yes, ongoing therapy allowed to continue
White - - -